Now 70, the victim of the shocking 1992 attack by her husband's teen mistress is narrating her shocking life story in Lifetime's 'I Am Mary Jo Buttafuoco' Janine Rubenstein is Editor-at-Large at ...

The morning of May 19, 1992, felt like any other for Mary Jo Buttafuoco. "I got the kids off to school, I cleaned the kitchen, I made the beds, I did all the mom stuff. And my plan that day was to ...

Vision tests are an important part of life, but they aren’t always the most convenient things to work into your schedule. It’s an issue Eyebot thinks it has solved with its kiosk, which shrinks the ...

CLEVELAND, Ohio — A wildlife camera in the Cleveland Metroparks has captured a sight not documented in Cuyahoga County for well over a century: a fisher, a once-vanished native mammal long believed to ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...

The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...

WASHINGTON — For the first time ever, American car companies will soon be required to test vehicle safety using dummies that are representative of women. Transportation Secretary Sean Duffy on ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Shares of Exact Sciences (EXAS) continued to rise in the premarket on Thursday, adding ~18% after the cancer test maker agreed to be acquired by Abbott Laboratories (ABT) in an all-cash deal worth ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ ...